Teladoc Health Statistics
Share Statistics
Teladoc Health has 175.44M
shares outstanding. The number of shares has increased by 2.41%
in one year.
| Shares Outstanding | 175.44M |
| Shares Change (YoY) | 2.41% |
| Shares Change (QoQ) | 0.87% |
| Owned by Institutions (%) | 75.04% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 895 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 20.23M, so 11.65% of the outstanding
shares have been sold short.
| Short Interest | 20.23M |
| Short % of Shares Out | 11.65% |
| Short % of Float | 15.07% |
| Short Ratio (days to cover) | 3.3 |
Valuation Ratios
The PE ratio is -1.55 and the forward
PE ratio is -8.06.
Teladoc Health's PEG ratio is
0.
| PE Ratio | -1.55 |
| Forward PE | -8.06 |
| PS Ratio | 0.6 |
| Forward PS | 0.4 |
| PB Ratio | 1.04 |
| P/FCF Ratio | 5.48 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Teladoc Health.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.77,
with a Debt / Equity ratio of 1.06.
| Current Ratio | 1.77 |
| Quick Ratio | 1.73 |
| Debt / Equity | 1.06 |
| Debt / EBITDA | -2.7 |
| Debt / FCF | 5.6 |
| Interest Coverage | -42.89 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $556,184.85 |
| Profits Per Employee | $-216,719.7 |
| Employee Count | 4,620 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 19.7 |
Taxes
| Income Tax | 7.59M |
| Effective Tax Rate | -0.76% |
Stock Price Statistics
The stock price has increased by -41.99% in the
last 52 weeks. The beta is 1.83, so Teladoc Health's
price volatility has been higher than the market average.
| Beta | 1.83 |
| 52-Week Price Change | -41.99% |
| 50-Day Moving Average | 7.92 |
| 200-Day Moving Average | 9.04 |
| Relative Strength Index (RSI) | 44.22 |
| Average Volume (20 Days) | 7,905,936 |
Income Statement
In the last 12 months, Teladoc Health had revenue of 2.57B
and earned -1B
in profits. Earnings per share was -5.87.
| Revenue | 2.57B |
| Gross Profit | 1.82B |
| Operating Income | -1.02B |
| Net Income | -1B |
| EBITDA | -587.01M |
| EBIT | -969.85M |
| Earnings Per Share (EPS) | -5.87 |
Full Income StatementBalance Sheet
The company has 1.3B in cash and 1.58B in
debt, giving a net cash position of -286.29M.
| Cash & Cash Equivalents | 1.3B |
| Total Debt | 1.58B |
| Net Cash | -286.29M |
| Retained Earnings | -16.23B |
| Total Assets | 3.44B |
| Working Capital | 649.41M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 293.68M
and capital expenditures -10.79M, giving a free cash flow of 282.89M.
| Operating Cash Flow | 293.68M |
| Capital Expenditures | -10.79M |
| Free Cash Flow | 282.89M |
| FCF Per Share | 1.66 |
Full Cash Flow StatementMargins
Gross margin is 70.76%, with operating and profit margins of -39.73% and -38.97%.
| Gross Margin | 70.76% |
| Operating Margin | -39.73% |
| Pretax Margin | -38.67% |
| Profit Margin | -38.97% |
| EBITDA Margin | -22.84% |
| EBIT Margin | -39.73% |
| FCF Margin | 11.01% |
